Chemoimmunotherapy Linked to HNSCC Response - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Chemoimmunotherapy Linked to HNSCC Response

Higher pathologic response rates with chemoimmunotherapy versus immunotherapy alone call for phase 3 trials, but survival implications remain unknown.

  • By

  • Andrea Surnit

  • June 5, 2026

  • 6 min

Share

Original Source(s)

Chemoimmunotherapy Linked to HNSCC Response

  • by Andrea Surnit

  • June 5, 2026

Related Content

Measurement Tools for Radiation-Induced Fibrosis in Head and Neck Cancer: A Systematic Review

AAE Revises Dental Trauma Guidance

Recommendations outline splinting, replantation timing, imaging, and long-term surveillance strategies for permanent tooth injuries.

Symptom Scores May Signal Neuropathy Risk

Early recovery symptom patterns may help clinicians identify which oropharyngeal cancer survivors warrant closer neurologic surveillance.